Introduction of Iobenguane I-131 Antineoplastic into Central Vein, Percutaneous Approach, New Technology Group 5 XW043S5
ICD-10-PCS code XW043S5 for Introduction of Iobenguane I-131 Antineoplastic into Central Vein, Percutaneous Approach, New Technology Group 5 is a medical classification as listed by CMS under Anatomical Regions range.
Official Code Descriptor
Introduction of Iobenguane I-131 Antineoplastic into Central Vein, Percutaneous Approach, New Technology Group 5
Crosswalks
Tabs
No record found
Crosswalk an ICD-10-PCS code to CPT®
Additional/Related Information
Tabs
| Section(X) | Body System(W) | Operation(0) | Body Part(4) | Approach(3) | Device / Substance / Technology(S) | Qualifier(5) |
| New Technology | Anatomical Regions | Introduction | Central Vein | Percutaneous | COVID-19 Vaccine Dose 1 | New Technology Group 5 |
No record found
| Change Type | Change Date | Previous Descriptor |
| Code Added | 10-01-2019 |
No need to flip from a code to the front of a book or to hunt through online PDFs to locate applicable chapter and block specific guidelines. See essential instructions from ICD-10-PCS Official Guidelines for Coding and Reporting right on your code details page.
